Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer

NCT02778685 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Carcinoma
Stage IV Breast Cancer AJCC v6 and v7

Interventions

DRUG: Fulvestrant
OTHER: Laboratory Biomarker Analysis
DRUG: Letrozole
DRUG: Palbociclib
BIOLOGICAL: Pembrolizumab

Sponsor

City of Hope Medical Center

Collaborators

[object Object]